Marker Therapeutics, Inc. (MRKR)
2.00
-0.07
(-3.38%)
USD |
NASDAQ |
Jan 09, 16:00
2.05
+0.05
(+2.50%)
Pre-Market: 20:00
Marker Therapeutics Market Cap: 33.35M for Jan. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 4.272B |
| Viridian Therapeutics, Inc. | 3.030B |
| Neurocrine Biosciences, Inc. | 13.54B |
| Kiniksa Pharmaceuticals International Plc | 3.234B |
| AIM ImmunoTech, Inc. | 0.9869M |
Market Cap Related Metrics
| PS Ratio | 5.423 |
| PEG Ratio | -0.1191 |
| Price to Book Value | 1.813 |
| Price | 2.00 |
| Earnings Yield | -61.45% |
| PEGY Ratio | -0.1191 |